Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02277925 · ClinicalTrials.gov registry record · NA

Permanent Versus Absorbable Colpopexy Trial

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
204
Enrollment target

NCT02277925 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 204 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02277925, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

Primary Aim: The primary aim of this randomized controlled trial (RCT) is to compare vaginal mesh and suture exposure rates in women undergoing robotic total hysterectomy and sacrocolpopexy with a light-weight polypropylene mesh (Upsylon™ y-mesh) using permanent (polytetrafluoroethylene, Gore-Tex) versus delayed absorbable monofilament (2-0 polydioxanone, PDS) sutures through 1-year. Secondary Aims: 1. To compare the 1-year composite success rate (leading edge of prolapse is at or above the hymen and apex has descended less than 1/3 of the vaginal length, no subjective feeling of bulge; and no retreatment for pelvic organ prolapse (POP) or vaginal mesh exposure) of permanent versus delayed absorbable sutures for mesh graft attachment during robotic total hysterectomy and sacrocolpopexy. 2. To evaluate adverse outcomes in each group

Interventions

  • OTHER Polytetrafluoroethylene
  • OTHER Polydioxanone

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2015-04-07
Est. Completion 2019-10-07
Phase NA

What the Registry Record Tells You About NCT02277925

The ClinicalTrials.gov registry entry for NCT02277925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Polytetrafluoroethylene is the first listed.

NCT02277925 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02277925 about?

NCT02277925 is a clinical study titled "Permanent Versus Absorbable Colpopexy Trial". Primary Aim: The primary aim of this randomized controlled trial (RCT) is to compare vaginal mesh and suture exposure rates in women undergoing robotic total hysterectomy and sacrocolpopexy with a light-weight polypropylene mesh (Upsylon™ y-mesh) using permanent (polytetrafluoroethylene, Gore-Tex) ...

What is the current status of trial NCT02277925?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2015-04-07. Estimated completion is 2019-10-07.

What interventions are being tested in trial NCT02277925?

The interventions under investigation include: Polytetrafluoroethylene (OTHER), Polydioxanone (OTHER).

Who is sponsoring clinical trial NCT02277925?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.